GenomeArc Horizon - a multi-OMICs Platform for Clinical Genomics
We envision a future where the genome serves as a compass, predicting diseases before they manifest, enabling personalized treatments, and enhancing human longevity. With that promise, GenomeArc proudly introduces our most advanced multi-OMICs platform, GenomeArc Horizon, designed for clinical genomics.
Let's plan for a demo request: https://genomearc.com/horizon
or Email: [email protected]
About GenomeArc:
GenomeArc Inc. is a biotech company on clinical genetics and drug discovery headquartered in Mississauga, Ontario. The company began its journey in 2021, GenomeArc develops artificial intelligence integrated solutions for genetic diagnosis and genomic drug development solutions for rare genetic disorders and pan cancer. As a research-oriented biotech company, GenomeArc brings new insights into rare diseases, cancer diagnosis, and therapeutics through genome analysis. The GenomeArc team is constantly innovating technologies to solve phenotypic complexities in genetic variations for rapid intervention. As a global company, our aim is to make efficient and accurate genome medicine technologies accessible for all healthcare systems.
#rarediseases #cancer #genomics #HorizonAI #clinicalAI #clinicalgenomics #liquidbiopsy #Genomics #CRISPR #GenomeArc #MohammedDafil #DubaiFutureFoundation #FutureOfMedicine #Biotech #PrecisionMedicine #DNA #GeneticEngineering #Innovation #Science #cancer #cancergenome #tumor #genes #genomics #machinelearning #largelanguagemodels #ai